Similar results have been previously described in cell models where CoCl2 is used as an hypoxia mimicking agent, and downregulation of CCL2 expression has been described in ovarian tumor cells [39] and monocytes and fibroblasts [40]. Here, CCL2 is linked to ovarian neoplasm.